Skip to main content

Acta Diabetologica

Ausgabe 5/2018

Inhalt (13 Artikel)

Review Article

Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells

Faruk H. Moonschi, Corey B. Hughes, George M. Mussman, John L. Fowlkes, Chris I. Richards, Iuliana Popescu

Original Article

Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow

Benfang Wang, Jianjiang Yu, Ting Wang, Ying Shen, Dandan Lin, Xin Xu, Yiqiang Wang

Original Article

Association between IgH enhancer hs1.2 and type 1 diabetes

Rossella Cianci, Pietro D’Addabbo, Giovanni Gambassi, Serena Lolli, Eliseo Serone, Alessandro Rizzi, Dario Pitocco, Franco Pandolfi, Domenico Frezza

Original Article

Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus®) and Lantus® in healthy subjects: a double-blind, randomized clamp study

Ashima Bhatia, Shraddha Tawade, Mushtaque Mastim, Eliford Ngaimisi Kitabi, Mathangi Gopalakrishnan, Manish Shah, Sridhar Yeshamaina, Joga Gobburu, Maharaj Sahib, Dipak Thakur, K. M. Prasanna Kumar

Original Article

The risk of type 2 diabetes mellitus according to the categories of body mass index: the Korean Genome and Epidemiology Study (KoGES)

Ju Young Jung, Sung Keun Park, Chang Mo Oh, Jae-Hong Ryoo, Joong-Myung Choi, Young Joon Choi

Open Access Original Article

Work-loss years among people diagnosed with diabetes: a reappraisal from a life course perspective

Mikaela B. von Bonsdorff, Monika E. von Bonsdorff, Maija Haanpää, Minna Salonen, Tuija M. Mikkola, Hannu Kautiainen, Johan G. Eriksson

Original Article

Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up

Emilia Huvinen, Johan G. Eriksson, Saila B. Koivusalo, Nora Grotenfelt, Aila Tiitinen, Beata Stach-Lempinen, Kristiina Rönö

Original Article

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials

Robert Puckrin, Marie-Philippe Saltiel, Pauline Reynier, Laurent Azoulay, Oriana H. Y. Yu, Kristian B. Filion

Short Communication

Soluble programmed death-1 ligand 1(sPD-L1) is significantly reduced in the serum of type 1 diabetes patients

Xiaohong Chen, Heming Guo, Sicheng Li, Cuiping Liu, Sisi Ding, Yun Huang, Chen Fang, Ji Hu

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.